More like this
- Medtronic CEO moves to defuse Infuse controversy
- Medtronic's bone-graft studies receive harsh criticism from spine journal
- Controversy over Medtronic's bone-graft product takes nasty, personal turn
- Could Infuse furor force Medtronic to sell spine business?
- Medtronic Infuse sales hurt by critical Spine Journal articles
PreferredOne customers will face rate hikes on MNsure. How much? A lot less than 63% — and a lot more than 4.525 comments